Psychedelic drugs and therapies continue to show promise as a form of treatment for a wide variety of mental health disorders.…
McAlinden Research PartnersOctober 18, 2021
Research into CRISPR gene editing technology continues to expand the amount of potential applications, while shrinking the actual size of proteins…
McAlinden Research PartnersSeptember 8, 2021
AI is transforming industries across every sector of the economy. Biotech and pharma are now experiencing a boom in AI initiatives…
McAlinden Research PartnersJuly 27, 2021
Promising developments in new gene editing trials continue to drive investor interest in the growing biotech sector. Potential advancements include the…
McAlinden Research PartnersJuly 22, 2021
Investment in the digital health sector continues to see strong growth in 2021, as funding in the first half of…
McAlinden Research PartnersJuly 8, 2021
Encouraging results from recent clinical trials testing the efficacy of using psychedelics like arketamine, LSD, and psilocybin to treat mental…
McAlinden Research PartnersMay 24, 2021
After COVID-19 brought record-setting investment to the healthcare industry in 2020, this year is shaping up to be even better.…
McAlinden Research PartnersApril 28, 2021
Automation is sweeping the global economy. Leading applications in the healthcare sector have the potential to save hospitals billions of…
McAlinden Research PartnersFebruary 10, 2021
Gene editing trials continue to heat up, as more and more labs initiate testing on humans. Genomics is increasingly popular among…
McAlinden Research PartnersFebruary 4, 2021
